This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Scrotum
CD2_BENIGN_SCROTUM_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly males |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D29
- Name in latin
- Neoplasma benignum scroti
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Scrotum
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Scrotum
- Benign neoplasm of male genital organs
- Benign neoplasm of male genital organs
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 145 | - | 145 |
| Unadjusted period prevalence (%) | 0.06 | - | 0.06 |
| Median age at first event (years) | 48.02 | - | 48.02 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 137
- Matched controls
- 1370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D29.4
ICD-10 Finland
Benign neoplasm: Scrotum
+∞
124.8
100
*
22288
ICD-8 Finland
Benign neoplasm of male genital organs, Loco alio definito
+∞
24.7
23
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
13.8
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
12.7
12
*
22280
ICD-8 Finland
Benign neoplasm of male genital organs, Scroti
+∞
12.7
12
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
9.5
8.6
17
20
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
35.7
8.2
10
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
84.5
7.5
8
*
130
Kela drug reimbursment
Malignant tumour
+∞
7.4
7
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
9.0
7.0
14
17
WF002
NOMESCO Finland
Radical radiotherapy
+∞
6.3
6
*
KFW96
NOMESCO Finland
Other operation on scrotum or scrotal organs
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
104
766
2.27
4.71
7.3
5.6
81.0
74.3
u/l
0.52
95
714
63
404
1.99
3.90
6.0
3.8
35.1
35.8
g/l
0.36
55
376
55
342
1.98
3.68
3.3
2.3
165.3
171.2
ug/l
0.09
50
310
61
396
1.93
3.58
4.3
3.6
—
—
—
0
0
83
603
1.88
3.40
4.8
4.4
6.3
6.9
mmol/l
2.96
77
571
97
753
1.87
3.10
3.6
3.7
11.5
10.3
mm/h
0.29
85
698
36
207
1.98
2.94
2.3
1.9
2.7
2.7
mg/l
0.02
27
174
16
65
2.64
2.90
3.6
2.0
72.5
63.6
ml/min/173m2
0.57
11
27
40
241
1.91
2.85
3.3
2.6
1.2
0.3
e6/l
0.37
33
171
63
447
1.72
2.59
6.5
5.8
1.2
1.2
mmol/l
2.07
48
386
72
532
1.70
2.54
9.4
6.9
3.9
4.4
e9/l
1.16
63
462
118
1006
1.93
2.46
16.1
10.9
82.6
81.3
ml/min/173m2
0.27
100
807
19
91
2.25
2.46
3.6
2.5
203.8
249.4
u/l
2.41
19
84
57
398
1.71
2.46
6.0
5.4
1.2
1.2
mmol/l
2.48
49
359
33
199
1.85
2.32
1.9
1.9
—
—
—
0
0
13
54
2.55
2.27
4.8
8.8
25.3
25.4
mmol/l
0.02
13
54
49
335
1.70
2.25
1.9
2.1
78.1
74.8
nmol/l
0.36
42
305
35
217
1.81
2.25
1.5
1.8
441.4
397.4
pmol/l
0.62
28
188
47
323
1.67
2.10
3.4
2.8
—
—
—
0
0
96
791
1.63
2.04
4.3
3.6
1.7
1.9
ug/l
0.34
87
712
119
1039
1.81
2.01
17.2
12.2
27.9
25.3
mg/l
0.29
99
803
54
389
1.62
2.00
1.9
1.9
84.4
90.8
pmol/l
0.45
30
216
5
11
4.66
1.95
3.8
1.8
3.1
2.2
u/ml
—
5
11
106
902
1.65
1.91
3.7
3.6
1.9
2.0
mu/l
0.22
96
815
29
185
1.71
1.68
1.5
1.8
1036.7
1250.7
nmol/l
0.70
20
148
6
19
3.25
1.68
1.0
1.5
—
—
—
0
0
84
697
1.49
1.53
3.1
2.8
14.4
14.9
pmol/l
1.25
78
626
77
631
1.47
1.48
2.2
2.7
—
—
—
0
0
88
741
1.48
1.46
3.1
3.2
60.5
56.4
u/l
0.20
80
705
127
1159
1.77
1.46
10.7
8.6
29.7
30.8
u/l
0.25
119
1113
38
281
1.48
1.19
4.3
2.1
2.4
2.3
mmol/l
1.10
33
242
8
39
2.11
1.17
1.3
1.3
—
—
—
0
0
13
73
1.86
1.15
1.5
1.4
—
—
—
0
0
24
162
1.58
1.13
3.0
2.0
11.4
15.6
nmol/l
2.76
19
153
7
31
2.32
1.12
1.3
1.3
0.0
0.2
g/l
—
7
26
7
31
2.32
1.12
1.3
1.2
40.6
37.0
g/l
—
7
21
29
208
1.49
1.05
4.1
3.8
552.5
570.5
ng/l
0.01
24
170
7
34
2.11
1.04
1.1
1.6
—
—
—
0
0
34
257
1.42
0.95
1.6
1.7
1.7
1.5
mmol/l
0.50
28
214
120
1117
1.43
0.85
5.0
5.1
2.6
2.7
mmol/l
0.47
109
1041
124
1161
1.47
0.85
19.8
14.1
89.5
86.9
umol/l
0.27
124
1161
114
1053
1.39
0.84
4.9
4.5
6.0
6.1
mmol/l
0.32
101
959
30
227
1.41
0.84
1.5
1.5
18.6
19.4
nmol/l
0.10
25
199
112
1033
1.37
0.82
7.1
6.2
40.7
40.7
mmol/mol
0.00
102
972
8
48
1.70
0.80
1.5
1.8
—
—
—
0
0
32
249
1.37
0.76
3.2
3.0
0.0
0.0
estimate
0.49
14
71
7
38
1.88
0.75
1.3
1.3
2.9
3.1
g/l
—
7
24
117
1101
1.32
0.63
4.6
4.6
4.3
4.5
mmol/l
0.73
110
1031
53
455
1.26
0.62
3.1
2.9
0.0
0.0
estimate
0.00
14
75
8
50
1.63
0.62
7.1
3.2
25.1
24.5
mmol/l
—
8
44
20
149
1.40
0.62
1.4
1.8
—
—
—
0
0
7
111
0.61
0.61
1.6
1.9
—
—
—
0
0
71
632
1.24
0.61
3.7
3.4
20.4
24.2
%
1.58
35
272
0
20
0.00
0.61
0.0
1.2
—
289.2
—
0
11
20
150
1.39
0.60
3.4
2.4
0.8
0.7
e6/l
0.10
11
84
52
449
1.25
0.58
2.7
2.5
0.6
0.7
ug/l
1.28
36
283
11
73
1.55
0.58
1.5
1.9
—
—
—
0
0
114
1073
1.29
0.58
4.2
4.1
1.4
1.4
mmol/l
0.09
106
999
8
55
1.48
0.57
1.6
1.5
—
—
—
0
0
19
145
1.36
0.52
3.8
2.6
0.5
0.5
e6/l
0.02
12
80
9
65
1.41
0.51
1.6
1.8
—
—
—
0
0
52
455
1.22
0.51
4.0
4.1
0.0
0.0
estimate
0.00
14
77
41
351
1.23
0.49
3.0
3.1
3399.7
1326.1
ng/l
1.10
31
293
43
371
1.23
0.48
3.3
3.0
—
—
—
0
0
53
469
1.20
0.46
3.0
2.9
0.0
0.0
estimate
0.00
14
71
115
1096
1.24
0.43
4.7
4.5
1.3
1.3
mmol/l
0.36
105
1020
5
32
1.58
0.42
4.0
3.7
—
—
—
0
0
5
33
1.53
0.42
1.2
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
14
106
1.36
0.41
1.4
1.8
—
—
—
0
0
5
36
1.40
0.38
1.0
1.0
—
—
—
0
0
20
163
1.26
0.36
2.3
1.9
30.8
29.5
s
0.34
20
158
25
210
1.23
0.36
1.6
1.5
0.7
1.1
mg/l
1.02
18
157
33
290
1.18
0.30
2.6
2.5
383.8
7524.8
umol/l
1.31
27
256
17
139
1.25
0.30
6.2
6.6
103.7
104.5
mmol/l
0.38
17
134
12
95
1.29
0.27
4.2
2.8
—
—
—
0
0
49
450
1.13
0.26
4.1
3.7
66.9
56.1
ng/l
0.11
35
334
12
146
0.81
0.23
1.3
1.3
20.9
29.6
iu/ml
—
5
46
13
107
1.24
0.22
1.5
1.9
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
16
136
1.20
0.21
5.8
4.9
27.0
29.6
%
—
10
97
0
13
0.00
0.21
0.0
4.6
—
—
—
0
0
9
115
0.77
0.20
1.8
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
1.4
—
0
7
9
109
0.81
0.13
7.9
3.0
6.1
5.8
kpa
—
9
104
6
55
1.09
0.09
9.5
10.8
23.9
25.0
mmol/l
—
6
46
17
184
0.91
0.08
1.2
1.3
4.5
1.5
u/ml
—
6
57
7
82
0.85
0.07
1.3
1.5
394.7
400.8
nmol/l
—
7
75
12
132
0.90
0.07
3.7
7.9
—
—
—
0
0
13
128
1.02
0.00
8.8
7.1
12.4
10.8
kpa
0.55
13
121
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
6
69
0.86
0.00
9.7
9.6
1.2
1.8
%
—
6
69
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
553.3
—
0
7
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
12.4
—
0
7
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_SCROTUM_EXALLC – Benign neoplasm: Scrotum
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).